Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: RE: ease2002

RE: ease2002

posted on May 04, 2006 11:53AM
Can PTSC make S and L reduce their holdings simply by buying shares on the open market and consequently raising their 9.99% threshold?

Would S and L require a premium to sell?

At $1 it would cost PTSC $70 million to buy S and L`s current holdings(10% of $700 million?). S and L could then exercise their remaining warrants and the o/s would still be as it is now.

Without a deal with S and L how can PTSC buy back shares?

Be well

Share
New Message
Please login to post a reply